79 件中 1 - 20 件目
英語 ：Yoshino R, Nakatsubo M, Ujiie N, Yoshida N, Yuzawa S, Kitada M. , Primary Chondrosarcoma of the Right Fourth Rib Resected at the Marginal Margin: A Case Report. , Cureus. , 15 (12) , 2023 , （IF:1.2）
英語 ：Ryusei Yoshino 1, Nana Yoshida 1, Nanami Ujiie 1, Masaki Nakatsubo 1, Mishie Tanino 2, Masahiro Kitada 1 , The Add-On Effect of Fluorouracil, Epirubicin, and Cyclophosphamide Regimens for Neoadjuvant Chemotherapy in Human Epidermal Receptor 2 (HER2)-Positive Breast Cancer: A Single-Center Retrospective Study , Cureus. , 15 (11) , 2023 , （IF:1.2）
英語 ：Yoshino R, Yoshida N, Ujiie N, Ito A, Nakatsubo M, Kamikokura Y, Kitada M. , Radiation-Associated Breast Angiosarcoma. , Cureus., 15 (10) , 2023 , （IF:1.2）
英語 ：Yoshino R, Yoshida N, Ito A, Ujiie N, Nakatsubo M, Hayashi M, Kitada M. , Granulomatous Mastitis Occurring during Pregnancy: A Case Report. , Medicina (Kaunas), 59 (8) , 2023 , （IF:2.6）
英語 ：Yoshino R, Yoshida N, Ujiie N, Ito A, Nakatsubo M, Tanino M, Kitada M. , Surgical Treatment of Secondary Pneumothorax-Complicated Interstitial Lung Disease. , Cureus. , 15 (8) , 2023 , （IF:1.2）
英語 ：Ito A, Nakatsubo M, Yoshino R, Yoshida N, Kitada M. , Two Cases of Breast Cancer With Gastric Metastasis. , Cureus. , 15 (8) , 2023 , （IF:1.2）
英語 ：Yoshino R, Yoshida N, Ito A, Ujiie N, Nakatsubo M, Kitada M. , Surgical resection of a large invasive mucinous adenocarcinoma: A case report. , Clin Case Rep, 11 (7) , 2023 , （IF:0.54）
英語 ：Yoshino R, Yoshida N, Ito A, Ujiie N, Nakatsubo M, Kamikokura Y, Kitada M , Subareolar Breast Abscess in a Male: A Case Report. , Cureus. , 15 (7) , 2023 , （IF:1.2）
英語 ：Yoshino R, Yoshida N, Ito A, Nakatsubo M, Yuzawa S, Kitada M. , Solitary fibrous tumor resembling pulmonary fractionation disease: A case report. , Medicine (Baltimore)., 102 (27) , 2023 , （IF:2.6）
英語 ：Yoshino R, Yoshida N, Yasuda S, Ito A, Nakatsubo M, Kitada M , A Case of Pneumothorax Ex Vacuo Associated with COVID-19. , Medicina (Kaunas)., 59 (4) （709 - ） , 2023 , （IF:2.6）
英語 ：Yoshino R, Yoshida N, Yasuda S, Ito A, Nakatsubo M, Kitada M , Primary Dedifferentiated Liposarcoma of the Posterior Mediastinum With a Positive Surgical Margin. , Cureus. , 15 (3) , 2023 , （IF:1.2）
英語 ：Abe Y, Taira N, Kashiwabara K, Tsurutani J, Kitada M, Takahashi M, Kato H, Kikawa Y, Sakata E, Naito Y, Hasegawa Y, Saito T, Iwasa T, Takashima T, Aihara T, Mukai H, Hara F, Shien T, Doihara H, Toyooka S. , Association of Genetic Polymorphism with Taxane-induced Peripheral Neuropathy: Sub-analysis of a Randomized Phase II Study to Determine the Optimal Dose of 3-week Cycle Nab-Paclitaxel in Metastatic Breast Cancer Patients. , Acta Med Okayama, 76 (6) （661 - 671） , 2022
英語 ：Aogi K, Watanabe K, Kitada M, Sangai T, Ohtani S, Aruga T, Kawaguchi H, Fujisawa T, Maeda S, Morimoto T, Sato N, Takao S, Morita S, Masuda N, Toi M, Ohno S. , Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19). , Int. J Clin Oncol. , 27 (11) （1793 - ） , 2022 , （IF:3.85）
英語 ：Uno Y, Tanaka H, Miyakawa K, Akiyama N, Kamikokura Y, Yuzawa S, Kitada M, Takei H, Tanino M , Subcellular localization of hTERT in breast cancer: insights into its tumorigenesis and drug resistance mechanisms in HER2-immunopositive breast cancer. , Hum Pathol. , 20 , 2022 , （IF:3.014）
英語 ：Yajima Y, Kosaka A, Ishibashi K, Yasuda S, Komatsuda H, Nagato T, Oikawa K, Kitada M, Takekawa M, Kumai T, Ohara K, Ohkuri T, Kobayashi H.Cancer Sci. , A tumor metastasis-associated molecule TWIST1 is a favorable target for cancer immunotherapy due to its immunogenicity. , Cancer Sci. , 113 (8) （2526 - 2535） , 2022 , （IF:6.518）
英語 ：Saji S, Taira N, Kitada M, Takano T, Takada M, Ohtake T, Toyama T, Kikawa Y, Hasegawa Y, Fujisawa T, Kashiwaba M, Ishida T, Nakamura R, Yamamoto Y, Toh U, Iwata H, Masuda N, Morita S, Ohno S, Toi M , Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial. , Lancet Oncol. , 23 (5) （636 - 649） , 2022 , （IF:54.433）
英語 ：Taira N, Kashiwabara K, Tsurutani J, Kitada M, Takahashi M, Kato H, Kikawa Y, Sakata E, Naito Y, Hasegawa Y, Saito T, Iwasa T, Takashima T, Aihara T, Mukai H, Hara F , Quality of life in a randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer. , Breast Cancer., 29 (1) （131 - 143） , 2022 , （IF:3.307）
英語 ：Kosaka A, Ishibashi K, Nagato T, Kitamura H, Fujiwara Y, Yasuda S, Nagata M, Harabuchi S, Hayashi R, Yajima Y, Ohara K, Kumai T, Aoki N, Komohara Y, Oikawa K, Harabuchi Y, Kitada M, Kobayashi H, Ohkuri , CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes. , J Exp Med, 218 (11) , 2021 , （IF:14.3）
英語 ：ogi K, Watanabe K, Kitada M, Sangai T, Ohtani S, Aruga T, Kawagichi H, Fujisawa T, Maeda S, Morimoto T, Sato N, Takao S, Morita S, Masuda N, Toi M, Ohno S. , Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19). , Int J Clin Oncol., 26 (7) （1229 - 1236） , 2021
英語 ：Aogi K, Watanabe K, Kitada M, Sangai T, Ohtani S, Aruga T, Kawagichi H, Fujisawa T, Maeda S, Morimoto T, Sato N, Takao S, Morita S, Masuda N, Toi M, Ohno , Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19). , J Clin Oncol, 26 (7) （1237 - ） , 2021 , （IF:5.65）
Copyright (C) 2012～ Asahikawa Medical University, All Rights Reserved.